(Q54150272)

25 May 2018

title

A pharmacokinetic study of adriamycin and 4'epi-adriamycin after simultaneous intra-arterial liver administration. (English)

1 reference

25 May 2018

1 reference

1 reference

S Eksborg

1

1 reference

25 May 2018

M Andersson

series ordinal

2

1 reference

25 May 2018

L Domellöf

series ordinal

3

1 reference

25 May 2018

U Lönroth

series ordinal

4

1 reference

25 May 2018

publication date

1 January 1986

1 reference

25 May 2018

Medical oncology and tumor pharmacotherapy

published in

1 reference

25 May 2018

volume

3

1 reference

25 May 2018

issue

2

1 reference

25 May 2018

page(s)

105-110

1 reference

25 May 2018

Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration

cites work

1 reference

12 December 2020

Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects

1 reference

12 December 2020

Liquid chromatography in anticancer drug research with special reference to anthraquinone glycosides

1 reference

12 December 2020

Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients

1 reference

12 December 2020

Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours.

1 reference

12 December 2020

Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology report

1 reference

12 December 2020

Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases

1 reference

12 December 2020

Adriamycin metabolism in man. Evidence from urinary metabolites

1 reference

12 December 2020

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

12 December 2020

A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil

1 reference

12 December 2020

Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol

1 reference

12 December 2020

A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin

1 reference

12 December 2020

Hepatic artery ligation and adriamycin infusion chemotherapy for hepatoma

1 reference

12 December 2020

Pharmacokinetic study of i.v. infusions of adriamycin

1 reference

12 December 2020

High-dose daunorubicin therapy for acute nonlymphocytic leukemia: correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity.

1 reference

12 December 2020

Pharmacokinetics of methotrexate administered via the hepatic artery

1 reference

12 December 2020

Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump

1 reference

12 December 2020

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

12 December 2020

Short-Term Intra-Arterial Mitomycin C in Hepatic Metastases

1 reference

12 December 2020

Effect of adriamycin on CFUGM at plasma concentrations found following therapeutic infusions

1 reference

12 December 2020

Epirubicin pharmacokinetics after intrahepatic arterial and intraperitoneal administration

1 reference

12 December 2020

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

12 December 2020

Phase II clinical evaluation of 4'-epi-doxorubicin

1 reference

12 December 2020

Identifiers

1 reference

25 May 2018